According to an internal analysis, 29.6% of studies that are highly likely to fall under mandatory reporting requirements have no results information submitted to ClinicalTrials.gov.
Read More…
FAST EU is directed to Facilitating and accelerating strategic clinical trials in the EU
Read More…
Spain, France, Germany, Italy and Poland have access to the largest numbers of drug trials.
Read More…
Ten Guiding Principles of Good AI Practice in Drug Development is mentioned in the guidance
Read More…
According to the report EMA recommended 104 medicines in 2025 and 38 had a new active substance. Also 16 medicines were approved for rare diseases including the first drug for Wiscott-ALdrich syndrome.
Read More…
We wish a peacefull year full of health and happiness
Read More…
The report on "Artificial intelligence in pharmacovigilance" addresses a rapidly emerging cross-disciplinary field that is at the intersection of pharmacovigilance, computer science, mathematics, regulation, law, medicine, human rights, psychology and social science.
Read More…
The MaP Toolbox gathers in one place more than 100 resources (and growing!) to support researchers in planning, designing, and conducting these complex trials.
Read More…
Due to funding cutoff of the USA government PubMed warns that it may not function properly…
Read More…
JAMA published an editorial on "Artificial Intelligence in Peer Review"
Read More…